Creating a consumer genetic test to predict your drug response

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

A personal genetics startup thinks that there is one set of DNA variants that everyone should know: the ones that help determine how you respond to drugs.

Genome Liberty, a New Jersey-based startup, wants to provide a $99 test that will tell customers, based on their genetics, if they should take a nonstandard dose of a drug because their body will break it down faster or slower than most people. In some cases the test might suggest a particular drug someone should take or avoid. “The idea is to give you a card to keep in your wallet, or an iPhone app, which says which medications you shouldn’t take,” says cofounder Jeffrey Rosenfeld, a genome scientist at Rutgers University.

Read the full, original story here: Consumer Genetic Test Can Predict Your Drug Response

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend